The shuttle walk exercise test in idiopathic pulmonary fibrosis

被引:27
作者
Moloney, ED
Clayton, N
Mukherjee, DK
Gallagher, CG
Egan, JJ
机构
[1] Univ Coll Dublin, Mater Misericordiae Hosp, Dept Resp Med, Dublin 2, Ireland
[2] Univ Coll Dublin, St Vincents Univ Hosp, Dept Resp Med, Dublin 2, Ireland
[3] S Manchester Univ Hosp NHS Trust, Wythenshawe Hosp, NW Lung Ctr, Manchester, Lancs, England
关键词
shuttle walk exercise test; idiopathic pulmonary fibrosis;
D O I
10.1053/rmed.2003.1501
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The shuttle walk test (SWT) is a validated, incremental walking test for chronic obstructive pulmonary disease, but not for idiopathic pulmonary fibrosis (IPF). The measurement of maximal oxygen consumption (VO2 max) is considered to be the gold standard measurement of functional capacity. This study examines the relationship between IPF patients' performance on the SWT and VO2 max. Twenty patients were recruited for the study, which consisted of two separate experiments. Firstly, the relationship between SWT performance on a conventional corridor SWT with that on a programmable treadmill SWT designed to reproduce the corridor SWT was examined (n = 10). In the second experiment, the relationship between performance on the treadmill equivalent SWT and VO2 max measurements was studied (n = 10). There was a significant correlation between distance walked on the corridor SWT and that walked on the treadmill equivalent SWT without VO2 max measurements (367 m vs 410 m) (r=0.91, P=0.0003),There was a significant correlation between distance walked on the treadmill equivalent SWT (277 m), and the directly determined VO2 max (14.87 ml/kg/min) (r=0.74, P=0.01). During both experiments, a significant correlation was also observed between baseline PaO2 and SWT performance, and between DLCO and SWT performance. The shuttle walk test is a simple objective measure of functional capacity in IPF patients, which should facilitate the evaluation of new therapeutic compounds for IPF. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:682 / 687
页数:6
相关论文
共 50 条
  • [21] Sildenafil Therapy and Exercise Tolerance in Idiopathic Pulmonary Fibrosis
    Robert M. Jackson
    Marilyn K. Glassberg
    Carol F. Ramos
    Pablo A. Bejarano
    Ghazwan Butrous
    Orlando Gómez-Marín
    Lung, 2010, 188 : 115 - 123
  • [22] Pulmonary rehabilitation in idiopathic pulmonary fibrosis: Predictors of adherence and exercise improvement
    Peasey, Maureen M.
    Nolan, Claire M.
    Kon, Samantha S. C.
    Canavan, Jane L.
    Jones, Sarah E.
    Clark, Amy L.
    Man, William D-C.
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [23] Validation of test performance characteristics and minimal clinically important difference of the 6-minute walk test in patients with idiopathic pulmonary fibrosis
    Nathan, Steven D.
    du Bois, Roland M.
    Albera, Carlo
    Bradford, Williamson Z.
    Costabel, Ulrich
    Kartashov, Alex
    Noble, Paul W.
    Sahn, Steven A.
    Valeyre, Dominique
    Weycker, Derek
    King, Talmadge E., Jr.
    RESPIRATORY MEDICINE, 2015, 109 (07) : 914 - 922
  • [24] The Prognostic Value of Cardiopulmonary Exercise Testing in Idiopathic Pulmonary Fibrosis
    Fell, Charlene D.
    Liu, Lyrica Xiaohong
    Motilka, Caroline
    Kazerooni, Ella A.
    Gross, Barry H.
    Travis, William D.
    Colby, Thomas V.
    Murray, Susan
    Toews, Galen B.
    Martinez, Fernando J.
    Flaherty, Kevin R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179 (05) : 402 - 407
  • [25] Prognostic value of clinical exercise testing in idiopathic pulmonary fibrosis
    Wallaert, B.
    Guetta, A.
    Wemeau-Stervinou, L.
    Terce, G.
    Valette, M.
    Neviere, R.
    Aguilaniu, B.
    REVUE DES MALADIES RESPIRATOIRES, 2011, 28 (03) : 290 - 296
  • [26] Benefits of pulmonary rehabilitation and predictor of changes in exercise capacity for idiopathic pulmonary fibrosis
    Mishima, Takuya
    Ogawa, Tomoya
    Watanabe, Fumiko
    Hirasawa, Jun
    Takurou, Furukawa
    Tanaka, Yuko
    Shingai, Kazuya
    Nagae, Yusuke
    Taniguchi, Hiroyuki
    Kondoh, Yasuhiro
    Kimura, Tomoki
    Kataoka, Kensuke
    Matsuda, Toshiaki
    Yokoyama, Toshiki
    Arizono, Shinichi
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [27] Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis
    Strykowski, Rachel
    Adegunsoye, Ayodeji
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2023, 43 (02) : 209 - 228
  • [28] Is It Idiopathic Pulmonary Fibrosis or Not?
    Salvatore, Mary
    Ishikawa, Genta
    Padilla, Maria
    JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2018, 31 (01) : 151 - 162
  • [29] Endurance Time Is the Most Responsive Exercise Measurement in Idiopathic Pulmonary Fibrosis
    Arizono, Shinichi
    Taniguchi, Hiroyuki
    Sakamoto, Koji
    Kondoh, Yasuhiro
    Kimura, Tomoki
    Kataoka, Kensuke
    Ogawa, Tomoya
    Watanabe, Fumiko
    Nishiyama, Osamu
    Nishimura, Koichi
    Kozu, Ryo
    Tabira, Kazuyuki
    RESPIRATORY CARE, 2014, 59 (07) : 1108 - 1115
  • [30] Effect of exercise pulmonary rehabilitation on long-term outcomes in idiopathic pulmonary fibrosis
    Vainshelboim, Baruch
    Oliveira, Jose
    Fox, Benjamin
    Kramer, Mordechai
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44